This topic contains a solution. Click here to go to the answer

Author Question: What prevents hostile accesses and protocols from passing from one part of the network to another? ... (Read 67 times)

Evvie72

  • Hero Member
  • *****
  • Posts: 519
What prevents hostile accesses and protocols from passing from one part of the network to another?
 
  A) The firewall B) The gateway
  C) The network switch D) The router

Question 2

The most probable cause for a pump that fails to discharge is _____.
 
  A) worn bearings in the pump motor B) an improperly sized motor
  C) a blockage in the lines D) shaft and coupling misalignment



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

harveenkau8139

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

A

Answer to Question 2

C




Evvie72

  • Member
  • Posts: 519
Reply 2 on: Jul 24, 2018
Great answer, keep it coming :)


xiaomengxian

  • Member
  • Posts: 311
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Nitroglycerin is used to alleviate various heart-related conditions, and it is also the chief component of dynamite (but mixed in a solid clay base to stabilize it).

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

Illness; diuretics; laxative abuse; hot weather; exercise; sweating; caffeine; alcoholic beverages; starvation diets; inadequate carbohydrate consumption; and diets high in protein, salt, or fiber can cause people to become dehydrated.

Did you know?

Illicit drug use costs the United States approximately $181 billion every year.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library